Tel：
(86)(21)60969600
Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
Shanghai, China – OnFebruary 1, Shanghai MicroPort EP MedTech Co., Ltd. (“MicroPort EP”) has recently obtained registration approval by theEgyptian Drug Authority (EDA) for its proprietary catheters, sheaths and otherequipment, marking its first entry into Egyptian market.
Arrhythmia is a common cardiovasculardisease, and severe arrhythmia is the main cause of sudden cardiac death.Radiofrequency ablation surgery is one of the most importantnon-pharmacological treatments for arrhythmias. The approved catheters, sheathsand equipment, including FireMagic™ Cardiac RF Ablation Catheter,FireMagic™ 3D Irrigated Ablation Catheter, EasyFinder™ Fixed Curve Diagnostic Catheter, EasyFinder™ Steerable Curve Diagnostic Catheter, EasyLoop™ Circular Mapping Catheter, PathBuilder™Transseptal Guiding Introducer, Columbus™ 3D EPNavigation System, Columbus™ Cardiac ElectrophysiologyStimulator, OptimAblate™ Cardiac RF Generator andOptimAblate™ Irrigation Pump, are intended for therapid diagnosis and effective treatment of arrhythmias.
The Egyptian Drug Authority approval meansthese products will soon enter the Egyptian market. These products will providea complete integrated therapeutic solution in electrophysiology for localpatients and doctors, laying a solid groundwork for the company’sfurther exploration in the Africa.
